article thumbnail

GSK sales of RSV vaccine stay strong, beating forecast

Bio Pharma Dive

The British drugmaker reported Arexvy sales of about $1.5 billion for 2023, higher than the range it had previously predicted for the year.

Sales 270
article thumbnail

Pfizer’s Covid-19 vaccine sales forecasts upgraded with sales of $37bn in 2022

Pharmaceutical Technology

Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, had a phenomenal year with forecast sales of $37bn in 2022. Comirnaty is the leading prophylactic vaccine for Covid-19 and is expected to generate an additional $2.8bn in sales in 2022 compared to GlobalData’s H1 2022 forecast. Comirnaty is the first globally approved Covid-19 vaccine.

Sales 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novo, Lilly buoyed by fast-growing GLP-1 drug sales

Bio Pharma Dive

The rival companies reported strong quarterly sales growth for their latest products, which could face off as weight loss treatments next year.

Sales 287
article thumbnail

GSK partners with Chinese pharma to expand Shingrix sales

Bio Pharma Dive

The purchase agreement with Chongqing Zhifei Biological Products is part of GSK’s plan to double sales of the shingles vaccine by 2026.

Sales 271
article thumbnail

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Are you currently in sales, or involved in a business that depends on strong sales results? What about the extremely competitive world of medical device sales? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC., Toastmasters Champion.

article thumbnail

How to Leverage Omnichannel & Sales Enablement Technologies for Pharmaceutical Sales Success

Pharma Mirror

In the fast-paced, highly competitive pharmaceutical industry, sales reps must adapt to new ways of engaging with customers and healthcare professionals (HCPs).

Sales 130
article thumbnail

Novo boosts sales outlook on strong demand for obesity drug

Bio Pharma Dive

The Danish drugmaker nearly doubled the 2023 forecasts for Wegovy and Ozempic in the latest indicator of the sales potential of an emerging and competitive class of weight loss drugs.

Sales 319